IP Library Granted Patent US 9,585,917
Granted Patent B2
US 9,585,917 · App. 13/205,511 · Granted Mar 7, 2017

Methods of producing pancreatic hormones

Inventors: Laura Martinson (San Diego, CA); Evert Kroon (San Diego, CA); Kevin D'Amour (San Diego, CA); Emmanuel Edward Baetge (Encinitas, CA)
Assignee: ViaCyte, Inc.
A61K35/39A61K38/26A61K38/28C12N5/0676C12N5/0678A61K35/12C12N2500/38C12N2501/10C12N2501/105C12N2501/113C12N2501/115C12N2501/119C12N2501/12C12N2501/16C12N2501/33C12N2501/385C12N2501/41C12N2501/415C12N2501/42C12N2501/58C12N2501/999C12N2506/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,585,917
App. No.
13/205,511
Granted
Mar 7, 2017
Kind
B2
Abstract

Disclosed herein are methods of producing pancreatic hormone-expressing cells by first differentiating pluripotent cells in cell culture so as to produce endodermal cells, the endodermal cells being competent to further differentiate into hormone-expressing cells capable of secreting at least one pancreatic hormone in response to a physiological signal, and then, transplanting the cultured endodermal cells into an organism, such as an organism in need of an endocrine cell therapy.

Claims (17)

1. A method for lowering blood glucose levels in a mammal, comprising the steps of:

(a) obtaining a population of human definitive endoderm cells;

(b) differentiating the population of definitive endoderm cells into a population of pancreatic endoderm and endocrine precursor cells using a medium comprising glucose, wherein the population expresses NKX6.1 and PDX1;

(c) transplanting the population of pancreatic endoderm and endocrine precursor cells into the mammal; and

(d) maturing the transplanted cells of step (c) into insulin secreting cells.

2. A method for lowering blood glucose levels in a mammal, comprising the steps of:

(a) obtaining a population of human definitive endoderm cells;

(b) differentiating the population of definitive endoderm cells into a population of pancreatic endoderm cells using a DMEM-high glucose medium;

(c) differentiating the population of pancreatic endoderm cells into a population of pancreatic endocrine precursor cells expressing NKX6.1 and PDX1, but not CDX2 using the DMEM-high glucose medium;

(d) transplanting the population of pancreatic endocrine precursor cells into the mammal; and

(e) maturing the transplanted cells of step (d) into insulin secreting cells.

3. A method for lowering blood glucose levels in a mammal, comprising the steps of:

(a) obtaining a population of human definitive endoderm cells;

(b) differentiating the population of definitive endoderm cells into a population of pancreatic endoderm cells using a DMEM-high glucose medium;

(c) differentiating the population of pancreatic endoderm cells into a population of pancreatic endocrine precursor cells expressing NKX6.1 and PDX 1, but not CDX2 using the DMEM-high glucose medium;

(d) differentiating the population of pancreatic endocrine precursor cells into a population of cells expressing insulin using the DMEM-high glucose medium; and

(e) transplanting into the mammal the population of insulin expressing cells.

Assignments (2)
CHANGE OF NAME Recorded Sep 23, 2016
From: CYTHERA, INC.
To: VIACYTE, INC.
Reel/Frame 040136/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2016
From: MARTINSON, LAURA; KROON, EVERT; D'AMOUR, KEVIN; BAETGE, EMMANUEL E.
To: CYTHERA, INC.
Reel/Frame 039846/0944 →
Continuity (7)
Continuation 12758734 · Apr 12, 2010
Continuation 11773944 · Jul 5, 2007
Continuation In Part 11681687 · Mar 2, 2007
Provisional Application 60852878 · Oct 18, 2006
Provisional Application 60833633 · Jul 26, 2006
Provisional Application 60778649 · Mar 2, 2006
Related Publication 20120009675A1 · Jan 12, 2012